Cemiplimab in Treating Patients With Recurrent and Resectable Stage II-IV Head and Neck Cutaneous Squamous Cell Cancer Before Surgery

Clinical trial NCT03565783 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03565783
Sponsor: M.D. Anderson Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck Stage II Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8

Start date: 2018-07-03
Primary completion: 2027-12-31
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.